Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register account icon
S&P 500
7,599.96
(
0.26%
)
US TECH 100
29,704.00
(
-0.02%
)
Dow Jones
51,078.88
(
0.00%
)
Brent Oil
93.34
(
-2.75%
)
Bitcoin
69,433.53
(
-2.71%
)
News Focus
News Focus

Replies to post #453684 on $Stock*Shop*Charts*News*Option$

Replies to #453684 on $Stock*Shop*Charts*News*Option$
icon url

Tuff-Stuff

03/29/12 3:08 PM

#453685 RE: joepcf #453684

Yep...saw the positive comments hitting everywhere
icon url

Tuff-Stuff

03/30/12 7:26 AM

#453831 RE: joepcf #453684

Vivus (VVUS) moves up 4.2% in premarket trading as the dust still clears from a FDA panel that had implications for weight-loss drug Qnexa. Yesterday's roller coaster ride for VVUS may have been a bit of a case of "itchy trader fingers" with the final word on FDA approval for Qnexa still up in the air.